Presentation
- Item #99203: Box containing 5 blisters of 10 x 1.7 ml glass cartridges
Risk Information
Reactions to Scandonest® are characteristic of those associated with
other amide-type local anesthetics. A major cause of adverse reactions
to this group of drugs is excessive plasma levels, which may be due to
overdosage, inadvertent intravascular injection or slow metabolic
degradation. Scandonest® is contraindicated in patients with a known
hypersensitivity to it or to any local anesthetic agent of the amide
type or to other components of mepivacaine solutions. Local anesthetics
should be employed only by clinicians who are well versed in diagnosis
and management of dose-related toxicity and other acute emergencies
which might arise from the block to be employed, and then only after
insuring the immediate availability of oxygen, other resuscitative
drugs, cardiopulmonary resuscitative equipment, and the personnel
resources needed for proper management of toxic reactions and related
emergencies. Scandonest® 2% L contains potassium metabisulfite, a
sulfite that may cause allergic-type reactions including anaphylactic
symptoms and life-threatening or less severe asthmatic episodes in
certain susceptible people. Please see package insert for prescribing
information.
Due to Health Canada policy this item is not returnable.
Due to Health Canada policy this item is not returnable.
